GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Carl Zeiss Meditec AFX.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

33.98

-2.80%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Carl Zeiss Meditec

Its shares trade on XETRA under the ticker AFX.DE. It has been listed since 20 March 2000. In the fiscal year to 30 September 2025, it reported revenue of €2.23bn and net income of €141.2m. At that date it held total assets of €3.46bn and shareholders' equity of €2.12bn.

Carl Zeiss Meditec AG engages in the development, manufacture and marketing of medical devices. The company is headquartered in Jena, Thueringen. The company went IPO on 2000-03-20. The company offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The firm has various production sites in Europe, the United States and Asia.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
20 Mar 2000
Employees
3,290

Leadership

Pay as last reported

  • Dr. Karl LamprechtIndependent Chairman of the Supervisory Board, since 2020€50,700
  • Mr. Maximilien FoerstPresident, Chief Executive Officer, Member of the Executive Board
  • Mr. Rene DennerDeputy Chairman of the Supervisory Board - Employee Representative, since 2019€55,600
  • Mr. Justus WehmerChief Financial Officer, Member of the Management Board€841,200
  • Mr. Falk BindheimMember of the Supervisory Board - Employee Representative€19,900
  • Ms. Isabel De PaoliMember of the Supervisory Board€36,000
  • Mr. Peter KameritschMember of the Supervisory Board€55,000
  • Ms. Brigitte KoblizekMember of the Supervisory Board - Employee Representative€36,000
  • Ms. Heike MadanMember of the Supervisory Board - Employee Representative€24,500
  • Mr. Jeffrey MarxMember of the Supervisory Board - Employee Representative€38,600
  • Mr. Stefan MullerMember of the Supervisory Board
  • Dr. Christian MunsterMember of the Supervisory Board - Employee Representative€22,500

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
85
Environment
99
Social
99
Governance
56
Direct emissions (scope 1)
58,158 t
Energy emissions (scope 2)
183,031 t
Value chain emissions (scope 3)
1,356,280 t
Women in the workforce
33%
Carbon reduction policy
Yes
Human rights policy
Yes

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.